Status: Not yet recruiting
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
This is a phase 1，randomized, double-blind, placebo-controlled, MAD study to evaluate the safety, tolerability and pharmacokinetics of oral LPM526000133 Fumarate Capsules (LY03017) in healthy adult subjects
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Luye Pharma Group Ltd.Updated: May 20, 2025Locations: 1
Eligibility criteria
Subject who voluntarily participate and sign the informed consent form. [+3]
Subject has a history of allergy to any component of the investigational drug or... [+18]